INLYTA cpr pell 5 mg 28 pce
7680622810039
CH-62281
L01EK01
07.16.1.
Reimbursement limitations:
INLYTA
Traitement de patients atteints d’un carcinome rénal avancé (RCC) après échec d’un traitement systémique préalable.
1 / 3
google
Details
- Product number
- 6228102
- CPT
- -
- Packaging group
- 28
- Unit
- Tablette(n)
- Composition
- axitinibum 5 mg, cellulosum microcristallinum, lactosum monohydricum, carmellosum natricum conexum corresp. natrium 0.37 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, triacetinum, E 171, E 172 (rubrum), pro compresso obducto corresp. lactosum monohydricum 58.8 mg.
Articles (1)
Inlyta 5 mg, Filmtabletten
Filmtabletten
28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.37 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
58.8 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1646.25
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2012
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 62281
- Drug name
- Inlyta, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01EK01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 10/04/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- INLYTA cpr pell 5 mg 28 pce
- Description (DE)
- INLYTA Filmtabl 5 mg 28 Stk
- Market launch
- 10/04/2012
- Narcotic (BTM)
- No